ECR is the official journal of the

CONTENT FOR HEALTHCARE PROFESSIONALS ONLY

CONTENT FOR HEALTHCARE PROFESSIONALS ONLY

This open-access and indexed, peer-reviewed journal publishes review articles ideal for the busy physician.

Topics

Current Volume

Special Collections icon

Special Collections

Previous Volumes icon

Previous Volumes

Videos

Submit Article

Featured

ESC 2021: Late-breaking Science Video Collection

ESC 2021: Late-breaking Science Video Collection

George D Dangas, Adrian P Banning, Davide Cao , et al

Innovations in Implantable Cardiac Monitoring in the COVID-19 Pandemic and Beyond

Implantable Cardiac Monitoring

ESC 2021 Discussion: The EMPEROR-Pooled Study

ESC 2021 Discussion: The EMPEROR-Pooled Study

Milton Packer, Harriette Van Spall

Introduction to Cardiovascular Health Concerns Among LGBTQ+ Populations

Introduction to Cardiovascular Health Concerns Among LGBTQ+ Populations

Introduction to CV Health Concerns Among LGBTQ+ Populations

Billy A Caceres, Carl Streed

ESC 21: Masterclass on The Global Burden of CV Disease in Women

ESC 21: Masterclass on The Global Burden of CV Disease in Women

Masterclass on The Global Burden of CV Disease in Women

Birgit Vogel, Harriette Van Spall

The LAAOS III Study: Surgical AFIB Ablation Evaluation

The LAAOS III Study: Surgical AFIB Ablation Evaluation

LAAOS III: Surgical AFIB Ablation Evaluation

Richard Whitlock

VOYAGER PAD: Rivaroxaban in Symptomatic PAD With & Without Comorbid Diabetes

VOYAGER PAD: Rivaroxaban in Symptomatic PAD With & Without Comorbid Diabetes

VOYAGER PAD: Rivaroxaban in PAD with & without Comorbid Diabete

Cecilia Low Wang

Invasive Diagnosis of Coronary Functional Disorders Causing Angina Pectoris

Invasive Diagnosis of Coronary Functional Disorders Causing Angina Pectoris

Sascha Beck , Valeria Martínez Pereyra , Andreas Seitz , et al

Cardio-oncology Discussion: Primary PCI in Cancer Patients

Cardio-oncology Discussion: Primary PCI in Cancer Patients

Cardio-oncology Discussion: Primary PCI in Cancer Patients

Arjun K Ghosh, Deepak Bhatt, Cezar Iliescu

ENVISAGE-TAVI AF: Edoxaban Noninferior to Warfarin for Adverse Events After TAVI

ENVISAGE-TAVI AF: Edoxaban Noninferior to Warfarin for Adverse Events After TAVI

ESC 2021: Results of the ENVISAGE-TAVI AF Trial

George D Dangas

Cardio-oncology Discussion: What to Do When the Systolic Function Falls During Breast Cancer Treatment

Cardio-oncology Discussion: What to Do When the Systolic Function Falls During Breast Cancer Treatment

What to Do When the Systolic Function Falls During Breast Cancer Treatment

Arjun K Ghosh, Rebecca Dobson, Elisavet Papadimitraki

Current Volume

CV Risk Biomarkers in Women with Prior Preeclampsia/HELLP Syndrome

,

,

,

Volume in progress

Published:

24 September 2021

Citation:

European Cardiology Review 2021;16:e36.

DOI:

https://doi.org/10.15420/ecr.2021.21

Views: 43
Downloads: 7

Imaging in Clinical and Subclinical Leaflet Thrombosis in TAVI

,

,

Helena Cigarrán

,

et al

Volume in progress

Published:

24 September 2021

Citation:

European Cardiology Review 2021;16:e35.

DOI:

https://doi.org/10.15420/ecr.2021.09

Views: 43
Downloads: 7

ISCHEMIA Trial: Key Questions and Answers

José López-Sendón

,

,

,

Volume in progress

Published:

14 September 2021

Citation:

European Cardiology Review 2021;16:e34.

DOI:

https://doi.org/10.15420/ecr.2021.16

Views: 209
Downloads: 26

Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases

,

,

Volume in progress

Published:

14 September 2021

Citation:

European Cardiology Review 2021;16:e33.

DOI:

https://doi.org/10.15420/ecr.2021.10

Views: 88
Downloads: 13

Timing of Intervention in Asymptomatic Patients with Aortic Stenosis

,

Ana Revilla-Orodea

,

J Alberto San Román

,

Volume in progress

Published:

03 September 2021

Citation:

European Cardiology Review 2021;16:e32.

DOI:

https://doi.org/10.15420/ecr.2021.11

Views: 205
Downloads: 21

The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease

,

,

,

Volume in progress

Published:

03 September 2021

Citation:

European Cardiology Review 2021;16:e31.

DOI:

https://doi.org/10.15420/ecr.2021.18

Views: 373
Downloads: 29

Pathophysiology and Diagnosis of Coronary Functional Abnormalities

,

,

Kensuke Nishimiya

,

et al

Volume in progress

Published:

03 September 2021

Citation:

European Cardiology Review 2021;16:e30.

DOI:

https://doi.org/10.15420/ecr.2021.23

Views: 298
Downloads: 29

TAVI in Challenging Scenarios

Sandra Santos-Martínez

,

Ignacio J Amat-Santos

,

Volume in progress

Published:

26 August 2021

Citation:

European Cardiology Review 2021;16:e29.

DOI:

https://doi.org/10.15420/ecr.2021.12

Views: 266
Downloads: 22

View all

Recently added

CV Risk Biomarkers in Women with Prior Preeclampsia/HELLP Syndrome

Esmee ME BoveeiD

,

Martha GulatiiD

,

Imaging in Clinical and Subclinical Leaflet Thrombosis in TAVI

María MartiniD

,

Javier CuevasiD

,

Helena CigarrániD

, et al

The ECR Podcast

Juan Carlos Kaski

RIPCORD 2: FFR During Angiography Did Not Improve Patient Outcomes

Nick Curzen

ISCHEMIA Trial: Key Questions and Answers

José López-SendóniD

,

,

Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases

Maki KomiyamaiD

,

Koji HasegawaiD

VOYAGER PAD: Rivaroxaban in PAD with & without Comorbid Diabete

Cecilia Low Wang

View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem

Introduction to CV Health Concerns Among LGBTQ+ Populations

Billy A Caceres, Carl Streed

ESC 2021 Discussion: The EMPEROR-Pooled Study

Milton Packer, Harriette Van Spall

Videos

Most Recent Most Viewed

RIPCORD 2: FFR During Angiography Did Not Improve Patient Outcomes

RIPCORD 2: FFR During Angiography Did Not Improve Patient Outcomes

RIPCORD 2: FFR During Angiography Did Not Improve Patient Outcomes

VOYAGER PAD: Rivaroxaban in Symptomatic PAD With & Without Comorbid Diabetes

VOYAGER PAD: Rivaroxaban in Symptomatic PAD With & Without Comorbid Diabetes

VOYAGER PAD: Rivaroxaban in PAD with & without Comorbid Diabete

Cecilia Low Wang

View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up

View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up

View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem

Introduction to Cardiovascular Health Concerns Among LGBTQ+ Populations

Introduction to Cardiovascular Health Concerns Among LGBTQ+ Populations

Introduction to CV Health Concerns Among LGBTQ+ Populations

Billy A Caceres, Carl Streed

ESC 2021 Discussion: The EMPEROR-Pooled Study

ESC 2021 Discussion: The EMPEROR-Pooled Study

Milton Packer, Harriette Van Spall

ESC 2021: Late-breaking Science Video Collection

ESC 2021: Late-breaking Science Video Collection

George D Dangas, Adrian P Banning, Davide Cao , et al

Cardio-oncology Discussion: What to Do When the Systolic Function Falls During Breast Cancer Treatment

Cardio-oncology Discussion: What to Do When the Systolic Function Falls During Breast Cancer Treatment

What to Do When the Systolic Function Falls During Breast Cancer Treatment

Arjun K Ghosh, Rebecca Dobson, Elisavet Papadimitraki

Cardio-oncology Discussion: Primary PCI in Cancer Patients

Cardio-oncology Discussion: Primary PCI in Cancer Patients

Cardio-oncology Discussion: Primary PCI in Cancer Patients

Arjun K Ghosh, Deepak Bhatt, Cezar Iliescu

SPLENDOR: Metabolic Surgery and Risk of MACE in NASH

SPLENDOR: Metabolic Surgery and Risk of MACE in NASH

SPLENDOR: Metabolic Surgery and Risk of MACE in NASH

TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

George D Dangas

RESPONSE-2: Benefits of Community-based Lifestyle Programme Were Lost After 1yr in CAD Patients

RESPONSE-2: Benefits of Community-based Lifestyle Programme Were Lost After 1yr in CAD Patients

RESPONSE-2: Long Term Outcomes of Lifestyle Programme in CAD Patients

Harald Thune Jorstad

STOPDAPT-2 ACT: 1-Month DAPT Followed by Clopidogrel Monotherapy in ACS

STOPDAPT-2 ACT: 1-Month DAPT Followed by Clopidogrel Monotherapy in ACS

STOPDAPT-2 ACT: 1-Month DAPT Followed by Clopidogrel Monotherapy in ACS

Hirotoshi Watanabe